Search results
Showing 121 to 135 of 152 results for copd
Chronic obstructive pulmonary disease: indacaterol/glycopyrronium (Ultibro Breezhaler) (ESNM33)
This evidence summary has been updated and replaced by NICE guideline 115.
Chronic obstructive pulmonary disease: umeclidinium inhaler (Incruse) (ESNM52)
This evidence summary has been updated and replaced by NICE guideline 115.
Chronic obstructive pulmonary disease: tiotropium/olodaterol (Spiolto Respimat) (ESNM72)
This evidence summary has been updated and replaced by NICE guideline 115.
Roflumilast for the management of severe chronic obstructive pulmonary disease (TA244)
This guidance has been updated and replaced by NICE technology appraisal guidance 461.
myCOPD for self-management of chronic obstructive pulmonary disease (MIB214)
This advice has been updated and replaced by NICE medical technologies guidance 68.
Mental health of adults in contact with the criminal justice system (NG66)
This guideline covers assessing, diagnosing and managing mental health problems in adults (aged 18 and over) who are in contact with the criminal justice system. It aims to improve mental health and wellbeing in this population by establishing principles for assessment and management, and promoting more coordinated care planning and service organisation across the criminal justice system.
Chronic obstructive pulmonary disease: fluticasone furoate plus vilanterol (ESNM21)
This evidence summary has been updated and replaced by NICE guideline 115.
Chronic obstructive pulmonary disease: beclometasone, formoterol and glycopyrronium (Trimbow) (ES17)
This evidence summary has been updated and replaced by NICE guideline 115.
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (CG101)
This guideline has been updated and replaced by NICE guideline NG115.
Evidence-based recommendations on artificial intelligence (AI)-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images.
This evidence summary has been updated and replaced by NICE guideline 115.
This evidence summary has been updated and replaced by NICE guideline 115.
Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)
NICE has developed a medtech innovation briefing (MIB) on the Alere Afinion CRP for C-reactive protein testing in primary care
NICE has developed a medtech innovation briefing (MIB) on SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea .
In development Reference number: GID-TA11808 Expected publication date: TBC